Histone Deacetylase Inhibitors as Cancer Therapeutics

Other | December 31, 2012

bySteven Grant, Steven Grant

not yet rated|write a review

Advances in Cancer Researchprovides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."



  • Provides invaluable information on the exciting and fast-moving field of cancer research
  • This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics"
  • Outstanding and original reviews

Pricing and Purchase Info

$184.00

In stock online
Ships free on orders over $25

From the Publisher

Advances in Cancer Researchprovides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."Provides invaluable information on the exciting and fast-moving field of cancer researchThis thematic volume looks at "Histone Deacety...

Format:OtherDimensions:288 pages, 1 × 1 × 1 inPublished:December 31, 2012Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123946085

ISBN - 13:9780123946089

Customer Reviews of Histone Deacetylase Inhibitors as Cancer Therapeutics

Reviews

Extra Content

Table of Contents

      1. Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
      2. Mechanisms of Resistance to Histone Deacetylase Inhibitors
      3. HDAC Inhibitors: Roles of DNA Damage and Repair
      4. HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
      5. Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
      6. Histone Deacetylase Inhibitors and Rational Combination Therapies
      7. HDAC Inhibitors and Chaperone Function